HMA/EMA multi-stakeholder workshop on artificial intelligence, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 20 November 2025, 13:30 (CET) to 21 November 2025, 12:45 (CET)

Human medicines European public assessment report (EPAR): Bridion, sugammadex, Date of authorisation: 25/07/2008, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Temodal, temozolomide, Date of authorisation: 26/01/1999, Revision: 40, Status: Authorised

Referral: Veterinary medicinal products containing amoxicillin, amoxicillin Article 141(1)(i) procedures Procedure started

Human medicines European public assessment report (EPAR): Quadramet, samarium [153Sm] lexidronam pentasodium, Date of authorisation: 04/02/1998, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Duavive, oestrogens conjugated,bazedoxifene, Date of authorisation: 16/12/2014, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Lenalidomide Mylan, lenalidomide, Date of authorisation: 18/12/2020, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Kymriah, tisagenlecleucel, Date of authorisation: 23/08/2018, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR): Increlex, mecasermin, Date of authorisation: 02/08/2007, Revision: 28, Status: Authorised

From laboratory to patients: How the safety of medicines is ensured in the Europen Union